As independent practices buckle under rising costs, administrative burdens and stagnant reimbursement, a new and unlikely cast of acquirers has entered the game, moving beyond the traditional hospital and health system playbook to stake claims across primary care and specialty medicine.
From insurers to pharmaceutical companies, here’s who is reshaping the physician acquisition landscape.